Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

BackgroundThere are sparse data on the long-term and late effects of hematopoietic cell transplantation (HCT) for sickle cell disease (SCD). ObjectiveThis study aims to establish an international registry of long-term outcomes post-HCT for SCD and demonstrate the...

Full description

Bibliographic Details
Main Authors: Lakshmanan Krishnamurti, Staci D Arnold, Ann Haight, Allistair Abraham, Gregory MT Guilcher, Tami John, Nitya Bakshi, Shalini Shenoy, Karen Syrjala, Paul L Martin, Sonali Chaudhury, Gretchen Eames, Olusola Festus Olowoselu, Matthew Hsieh, Josu De La Fuente, Kimberly A Kasow, Elizabeth Stenger, Anne Mertens, Fuad El-Rassi, Peter Lane, Bronwen E Shaw, Lillian Meacham, David Archer
Format: Article
Language:English
Published: JMIR Publications 2022-07-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2022/7/e36780
_version_ 1797734912985399296
author Lakshmanan Krishnamurti
Staci D Arnold
Ann Haight
Allistair Abraham
Gregory MT Guilcher
Tami John
Nitya Bakshi
Shalini Shenoy
Karen Syrjala
Paul L Martin
Sonali Chaudhury
Gretchen Eames
Olusola Festus Olowoselu
Matthew Hsieh
Josu De La Fuente
Kimberly A Kasow
Elizabeth Stenger
Anne Mertens
Fuad El-Rassi
Peter Lane
Bronwen E Shaw
Lillian Meacham
David Archer
author_facet Lakshmanan Krishnamurti
Staci D Arnold
Ann Haight
Allistair Abraham
Gregory MT Guilcher
Tami John
Nitya Bakshi
Shalini Shenoy
Karen Syrjala
Paul L Martin
Sonali Chaudhury
Gretchen Eames
Olusola Festus Olowoselu
Matthew Hsieh
Josu De La Fuente
Kimberly A Kasow
Elizabeth Stenger
Anne Mertens
Fuad El-Rassi
Peter Lane
Bronwen E Shaw
Lillian Meacham
David Archer
author_sort Lakshmanan Krishnamurti
collection DOAJ
description BackgroundThere are sparse data on the long-term and late effects of hematopoietic cell transplantation (HCT) for sickle cell disease (SCD). ObjectiveThis study aims to establish an international registry of long-term outcomes post-HCT for SCD and demonstrate the feasibility of recruitment at a single site in the United States. MethodsThe Sickle Cell Transplantation Evaluation of Long-Term and Late Effects Registry (STELLAR) was designed to enroll patients with SCD ≥1 year post-HCT, their siblings without SCD, and nontransplanted controls with SCD to collect web-based participant self-reports of health status and practices by using the Bone Marrow Transplant Survivor Study (BMTSS) surveys, health-related quality of life (HRQOL) using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Profile-25 or Pediatric Profile-29 survey, chronic graft-versus-host disease (cGVHD) using the symptom scale survey, daily pain using an electronic pain diary, the economic impact of HCT using the financial hardship survey, sexual function using the PROMIS Sexual Function SexFSv2.0 survey, and economic productivity using the American Time Use Survey (ATUS). We also piloted retrieval of clinical data previously submitted to the Center for International Blood and Marrow Transplant Research (CIBMTR); recorded demographics, height, weight, blood pressure, waist and hip circumferences, timed up and go (TUG) test, and handgrip test; and obtained blood for metabolic screening, gonadal function, fertility potential, and biorepository of plasma, serum, RNA, and DNA. ResultsOf 100 eligible post-HCT patients, we enrolled 72 (72%) participants aged 9-38 (median 17) years. We also enrolled 19 siblings aged 5-32 (median 10) years and 28 nontransplanted controls with SCD aged 4-46 (median 22) years. Of the total 119 participants, 73 (61%) completed 85 sets of surveys and 41 (35%) contributed samples to the biorepository. We completed ATUS interviews of 28 (24%) participants. We successfully piloted retrieval of data submitted to the CIBMTR and expanded recruitment to multiple sites in the United States, Canada, the United Kingdom, and Nigeria. ConclusionsIt is feasible to recruit subjects and conduct study procedures for STELLAR in order to determine the long-term and late effects of HCT for SCD. International Registered Report Identifier (IRRID)DERR1-10.2196/36780
first_indexed 2024-03-12T12:51:12Z
format Article
id doaj.art-30e5d87919a54832b17b351f26b0d417
institution Directory Open Access Journal
issn 1929-0748
language English
last_indexed 2024-03-12T12:51:12Z
publishDate 2022-07-01
publisher JMIR Publications
record_format Article
series JMIR Research Protocols
spelling doaj.art-30e5d87919a54832b17b351f26b0d4172023-08-28T22:42:17ZengJMIR PublicationsJMIR Research Protocols1929-07482022-07-01117e3678010.2196/36780Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurtihttps://orcid.org/0000-0003-3242-0037Staci D Arnoldhttps://orcid.org/0000-0001-6053-8521Ann Haighthttps://orcid.org/0000-0001-8158-0091Allistair Abrahamhttps://orcid.org/0000-0003-2019-0887Gregory MT Guilcherhttps://orcid.org/0000-0001-9380-4347Tami Johnhttps://orcid.org/0000-0003-0632-3559Nitya Bakshihttps://orcid.org/0000-0002-0876-9506Shalini Shenoyhttps://orcid.org/0000-0002-9283-607XKaren Syrjalahttps://orcid.org/0000-0001-8378-2797Paul L Martinhttps://orcid.org/0000-0001-8141-5678Sonali Chaudhuryhttps://orcid.org/0000-0001-9696-3159Gretchen Eameshttps://orcid.org/0000-0003-3274-3207Olusola Festus Olowoseluhttps://orcid.org/0000-0002-3125-6311Matthew Hsiehhttps://orcid.org/0000-0002-3706-6615Josu De La Fuentehttps://orcid.org/0000-0002-0974-1249Kimberly A Kasowhttps://orcid.org/0000-0002-0651-8666Elizabeth Stengerhttps://orcid.org/0000-0002-1386-6685Anne Mertenshttps://orcid.org/0000-0003-0858-2482Fuad El-Rassihttps://orcid.org/0000-0002-8583-0526Peter Lanehttps://orcid.org/0000-0001-5887-6222Bronwen E Shawhttps://orcid.org/0000-0003-3317-1896Lillian Meachamhttps://orcid.org/0000-0003-4394-0070David Archerhttps://orcid.org/0000-0002-9185-0865 BackgroundThere are sparse data on the long-term and late effects of hematopoietic cell transplantation (HCT) for sickle cell disease (SCD). ObjectiveThis study aims to establish an international registry of long-term outcomes post-HCT for SCD and demonstrate the feasibility of recruitment at a single site in the United States. MethodsThe Sickle Cell Transplantation Evaluation of Long-Term and Late Effects Registry (STELLAR) was designed to enroll patients with SCD ≥1 year post-HCT, their siblings without SCD, and nontransplanted controls with SCD to collect web-based participant self-reports of health status and practices by using the Bone Marrow Transplant Survivor Study (BMTSS) surveys, health-related quality of life (HRQOL) using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Profile-25 or Pediatric Profile-29 survey, chronic graft-versus-host disease (cGVHD) using the symptom scale survey, daily pain using an electronic pain diary, the economic impact of HCT using the financial hardship survey, sexual function using the PROMIS Sexual Function SexFSv2.0 survey, and economic productivity using the American Time Use Survey (ATUS). We also piloted retrieval of clinical data previously submitted to the Center for International Blood and Marrow Transplant Research (CIBMTR); recorded demographics, height, weight, blood pressure, waist and hip circumferences, timed up and go (TUG) test, and handgrip test; and obtained blood for metabolic screening, gonadal function, fertility potential, and biorepository of plasma, serum, RNA, and DNA. ResultsOf 100 eligible post-HCT patients, we enrolled 72 (72%) participants aged 9-38 (median 17) years. We also enrolled 19 siblings aged 5-32 (median 10) years and 28 nontransplanted controls with SCD aged 4-46 (median 22) years. Of the total 119 participants, 73 (61%) completed 85 sets of surveys and 41 (35%) contributed samples to the biorepository. We completed ATUS interviews of 28 (24%) participants. We successfully piloted retrieval of data submitted to the CIBMTR and expanded recruitment to multiple sites in the United States, Canada, the United Kingdom, and Nigeria. ConclusionsIt is feasible to recruit subjects and conduct study procedures for STELLAR in order to determine the long-term and late effects of HCT for SCD. International Registered Report Identifier (IRRID)DERR1-10.2196/36780https://www.researchprotocols.org/2022/7/e36780
spellingShingle Lakshmanan Krishnamurti
Staci D Arnold
Ann Haight
Allistair Abraham
Gregory MT Guilcher
Tami John
Nitya Bakshi
Shalini Shenoy
Karen Syrjala
Paul L Martin
Sonali Chaudhury
Gretchen Eames
Olusola Festus Olowoselu
Matthew Hsieh
Josu De La Fuente
Kimberly A Kasow
Elizabeth Stenger
Anne Mertens
Fuad El-Rassi
Peter Lane
Bronwen E Shaw
Lillian Meacham
David Archer
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
JMIR Research Protocols
title Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
title_full Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
title_fullStr Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
title_full_unstemmed Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
title_short Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
title_sort sickle cell transplantation evaluation of long term and late effects registry stellar to compare long term outcomes after hematopoietic cell transplantation to those in siblings without sickle cell disease and in nontransplanted individuals with sickle cell disease design and feasibility study
url https://www.researchprotocols.org/2022/7/e36780
work_keys_str_mv AT lakshmanankrishnamurti sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT stacidarnold sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT annhaight sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT allistairabraham sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT gregorymtguilcher sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT tamijohn sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT nityabakshi sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT shalinishenoy sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT karensyrjala sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT paullmartin sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT sonalichaudhury sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT gretcheneames sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT olusolafestusolowoselu sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT matthewhsieh sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT josudelafuente sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT kimberlyakasow sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT elizabethstenger sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT annemertens sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT fuadelrassi sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT peterlane sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT bronweneshaw sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT lillianmeacham sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy
AT davidarcher sicklecelltransplantationevaluationoflongtermandlateeffectsregistrystellartocomparelongtermoutcomesafterhematopoieticcelltransplantationtothoseinsiblingswithoutsicklecelldiseaseandinnontransplantedindividualswithsicklecelldiseasedesignandfeasibilitystudy